Published in Histopathology on January 01, 2006
Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One (2012) 1.66
Characterization of intestinal inflammation and identification of related gene expression changes in mdr1a(-/-) mice. Genes Nutr (2007) 1.04
Old-age inflammatory bowel disease onset: a different problem? World J Gastroenterol (2011) 1.00
Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol (2012) 0.97
Inflammatory bowel disease unclassified. J Zhejiang Univ Sci B (2011) 0.94
Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. BMC Immunol (2010) 0.93
Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol (2008) 0.88
The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch (2014) 0.86
Microdevice to capture colon crypts for in vitro studies. Lab Chip (2010) 0.84
Clear cell colitis: a form of microscopic colitis in children. World J Gastroenterol (2008) 0.83
Indeterminate colitis. Tech Coloproctol (2007) 0.83
Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population. J Negat Results Biomed (2012) 0.79
Dietary ganglioside reduces proinflammatory signaling in the intestine. J Nutr Metab (2012) 0.79
The histopathological mimics of inflammatory bowel disease: a critical appraisal. Tech Coloproctol (2015) 0.79
Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review. World J Gastroenterol (2014) 0.77
Restorative proctocolectomy for inflammatory bowel disease: the Padova prognostic score for colitis in predicting long-term outcome and quality of life. Int J Colorectal Dis (2009) 0.76
Crohn's disease-associated Escherichia coli survive in macrophages by suppressing NFκB signaling. Inflamm Bowel Dis (2014) 0.76
Endothelial Fas-Ligand in Inflammatory Bowel Diseases and in Acute Appendicitis. J Histochem Cytochem (2015) 0.75
Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease. World J Gastroenterol (2015) 0.75
Diagnosis and therapy of microscopic colitis with presence of foamy macrophages in children. ISRN Gastroenterol (2011) 0.75
Transmural inflammation is not pathognomonic for Crohn's disease of the pouch. Surg Endosc (2011) 0.75
The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell (2001) 2.53
Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology (1999) 2.20
Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology (1994) 1.66
The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer (1999) 1.65
Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol (2001) 1.37
HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma. Hum Pathol (2000) 1.30
Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol (2001) 1.24
Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol (2001) 1.22
MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker. Hum Pathol (1997) 1.21
Hyperplastic polyp with epithelial misplacement (inverted hyperplastic polyp): a clinicopathologic and immunohistochemical study of 19 cases. Mod Pathol (2001) 1.15
P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am J Surg Pathol (1999) 1.04
Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol (1998) 1.03
Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis. Mod Pathol (1997) 1.01
Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy. Mod Pathol (1999) 0.98
Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol (2001) 0.97
Multinucleated epithelial giant cell changes in esophagitis: a clinicopathologic study of 14 cases. Am J Surg Pathol (1998) 0.92
Gastric fundic gland polyps: are they preneoplastic lesions? Gastroenterology (1998) 0.91
Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients. Cancer (1999) 0.89
Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma. Hum Pathol (1999) 0.88
Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction. Hum Pathol (1999) 0.87
Polypoid dysplasia in Barrett's esophagus: a clinicopathologic, immunohistochemical, and molecular study of five cases. Hum Pathol (1999) 0.87
Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum Pathol (1997) 0.86
Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma. Br J Cancer (2001) 0.82
Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients. Cancer Res (1993) 0.81
Relationship of Bcl-2 expression with apoptosis and proliferation in colonic graft versus host disease. Hum Pathol (1998) 0.81
Gastric dysplasia-like epithelial atypia associated with chemoradiotherapy for esophageal cancer: a clinicopathologic and immunohistochemical study of 15 cases. Mod Pathol (2001) 0.81
Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients. Oncogene (1995) 0.81
Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine. Hum Pathol (1999) 0.81
Proliferative characteristics of intestinalized mucosa in the distal esophagus and gastroesophageal junction (short-segment Barrett's esophagus): a case control study. Hum Pathol (1999) 0.80
Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma. Cancer (2001) 0.80
Preoperative chemoradiotherapy alters the expression and prognostic significance of adhesion molecules in Barrett's-associated adenocarcinoma. Hum Pathol (2000) 0.77
Growth factor expression and proliferation kinetics in periampullary neoplasms in familial adenomatous polyposis. Cancer (1995) 0.76
Skip lesions in ulcerative colitis. Am J Gastroenterol (1998) 0.75
Proliferative characteristics of differentiated cells in familial adenomatous polyposis-associated duodenal adenomas. Hum Pathol (1996) 0.75
Cytomegalovirus infection in the colon of bone marrow transplantation patients. Mod Pathol (1998) 0.75